Ido Laskov

Title: Ido Laskov: Innovator in Cancer Treatment

Introduction

Ido Laskov is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and development of T-cell therapies. His work focuses on enhancing the efficacy of T-cells in targeting specific cancer antigens.

Latest Patents

Ido Laskov holds a patent for "T-cells comprising two different chimeric antigen receptors and uses thereof." This invention provides T-cells modified to express at least two chimeric antigen receptors. One of the CARs binds specifically to an antigen selected from CD138, HER2, and CD24, while another CAR binds specifically to a different antigen selected from the same list. The invention also includes pharmaceutical compositions comprising these CAR T-cells and their application in treating cancer, particularly ovarian cancer. Additionally, it covers DNA constructs encoding the CARs and methods for preparing T-cells that express these CARs.

Career Highlights

Throughout his career, Ido Laskov has worked with notable organizations, including the Medical Research Infrastructure and Health Services Fund of the Tel Aviv Medical Center and Yeda Research and Development Company Ltd. His expertise in the field has led to advancements in cancer therapies and has positioned him as a key figure in medical research.

Collaborations

Ido Laskov has collaborated with esteemed colleagues such as Zelig Eshhar and Tova Waks. These partnerships have contributed to the development of innovative solutions in cancer treatment.

Conclusion

Ido Laskov's contributions to the field of cancer treatment through his patented innovations highlight his role as a leading inventor. His work continues to pave the way for advancements in medical therapies aimed at improving patient outcomes.